LTT Bio-Pharma Wins Governmental Backing for Its Collaborative Research on Nonsteroidal Antiinflammatory Drug.
Further, the company and JST signed a three-year contract on August 1. Under this contract, the company, in collaboration with Professor Tohru Mizushima at the Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, will proceed with research on next-generation nonsteroidal anti-inflammatory drugs.
Specifically, they aim to develop agents that will be free from developing gastric ulcer and myocardial infarction.
JST will provide the project with a fund of 50 million yen ($450,000) for fiscal 2005.
Source: JCN http://www.japancorp.net
Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
|Printer friendly Cite/link Email Feedback|
|Publication:||JCNN News Summaries|
|Date:||Aug 5, 2005|
|Previous Article:||National Institute of Agrobiological Sciences Successfully Controls Silkworm's Metamorphosis.|
|Next Article:||Kyorin Pharmaceutical to License Its Overactive Bladder Drug to Korean LG Life Sciences.|